Latest content
- Eli Lilly to acquire Kelonia Therapeutics in deal worth up to $7bn
- MHRA authorises Biogen’s higher-dose Spinraza for SMA treatment
- Beyond the injection: why the real work of weight loss starts where the drug leaves off
- J&J’s Icotyde approved by US FDA for plaque psoriasis
- Envision appoints Darren Coleman as Executive VP, Chief Information Officer